Prediabetes Screening: When to Ask About A1C and Blood Glucose Tests

Who is included in the screening recommendation?

The U.S. Preventive Services Task Force recommends screening nonpregnant adults ages 35–70 who have overweight or obesity and no diabetes symptoms. Individual risk can support screening outside this group.

This recommendation is not a rule that nobody outside that group needs testing. A clinician considers individual circumstances and other applicable guidance. Pregnancy-related testing follows a separate approach. Bring questions rather than trying to decide from age or weight alone.

How are A1C and blood glucose tests different?

NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains that A1C reflects average blood glucose over roughly three months. A1C testing itself does not require fasting. It provides a different view from a single glucose measurement.

NIDDK’s testing guide describes fasting plasma glucose as a measurement at one point in time after fasting. An oral glucose tolerance test measures the response after a glucose drink. Your clinician chooses the test based on the situation; these are not interchangeable home experiments.

Ask which test was ordered, where to have it done, and whether other laboratory orders change the preparation. Do not skip meals, change medicines, or arrange your own glucose-drink test based on this article. Follow the specific instructions from your care team and laboratory.

What should you tell your clinician before testing?

• Previous results: Bring dates, test names, and the actual reports when available.
• Family and pregnancy history: Mention relatives with diabetes and any history of gestational diabetes.
• Current health information: Include medicines, supplements, relevant diagnoses, recent illness, and pregnancy or possible pregnancy.
• Practical concerns: Tell the team if transportation, fasting, work hours, cost, or understanding instructions may make testing difficult.

NIDDK notes that some conditions and hemoglobin variants can make A1C results misleading. Tell the clinician about known blood conditions and ask whether anything in your history affects test selection. Do not assume that a mismatch between tests means either result should simply be ignored.

What happens after an abnormal result?

A flagged laboratory value needs interpretation in context. NIDDK explains that repeat or additional testing is generally used to confirm diabetes in people without symptoms. Ask the clinician to name the result, explain whether confirmation is needed, and specify the next step and its timing.

Try these questions: “What does this result show—and what does it not show?” “Do I need another test?” “Who will contact me, and when should I call if I have not heard?” Keep a copy of the plan so a portal notification does not become the end of follow-up.

If prediabetes is identified, the USPSTF recommends offering or referring patients to effective preventive interventions. Ask about an appropriate structured program and support that fits your circumstances. A screening result is not a reason to start someone else’s medicine, follow an extreme diet, or expect a guaranteed outcome.

When should a normal result be rechecked?

The USPSTF says the best screening interval is uncertain; repeating about every three years may be reasonable after normal blood glucose results. That is a starting point for a clinician discussion, not a promise that everyone can wait that long.

Before leaving, ask for a follow-up date and what changes should prompt an earlier conversation. Our primary-care follow-up checklist helps organize results and questions; the preventive-care checklist covers other topics to review.

Do not confuse symptom evaluation with screening

NIDDK advises testing people who have diabetes symptoms. New excessive thirst or more frequent urination should be discussed promptly with a healthcare professional rather than dismissed because of a prior normal screen. Symptoms can have different causes and cannot establish a diagnosis by themselves.

If you are acutely unwell, seek timely medical care rather than relying on a blog or routine online booking. Call 911 for a medical emergency.

Clarify costs and the follow-up process

Ask whether the laboratory bills separately from the visit, whether the order is for screening or evaluation, and what your insurer or self-pay arrangement covers. Do not assume that a guideline recommendation guarantees no-cost testing. Review our self-pay estimate guide for questions about expected charges.

Write down one concrete next action: scheduling the lab, obtaining an old result, confirming instructions, or booking a result-review visit. The useful endpoint is an understood plan, not simply a test order.